Biomea Fusion, Inc. Increase (Decrease) in Accrued Liabilities
Biomea Fusion, Inc. (BMEA) reported Increase (Decrease) in Accrued Liabilities of $1.09 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-27.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2021-05-27
- Biomea Fusion, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-03-31 was $1.09M, a 1749.15% increase year-over-year.
- Biomea Fusion, Inc. increase (decrease) in accrued liabilities for the quarter ending 2020-03-31 was $59.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month |
|---|---|
| 2021-03-31 | $1.09M 10-Q · filed 2021-05-27 |
| 2020-03-31 | $59.00K 10-Q · filed 2021-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |